TTK HEALTHCARE LTD.
NSE : TTKHLTCAREBSE : 507747ISIN
CODE : INE910C01018Industry : Pharmaceuticals & DrugsHouse
: TTK
BSE1508.000 (0 % )
PREV CLOSE (Rs.) 1508.00
OPEN PRICE (Rs.) 1515.55
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 339
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE1515.35 -0.2 (-0.01 % )
PREV CLOSE(Rs.) 1515.55
OPEN PRICE (Rs.) 1515.05
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 336
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Company News
| Date | Heading | Details |
|---|---|---|
| 22-Dec-2023 | Ttk Healthcare informs about clarification | <div style="text-align: justify;">With acknowledge receipt of communication L/SURV/ONL/PV/NP/2023-2024/497 dated 22nd December, 2023, Ttk Healthcare has clarified that the company as of now, do not have any information / announcement (including impending announcement) about the Company which in its opinion may have a bearing on the price / volume behaviour in the scrip.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 21-Nov-2023 | Ttk Healthcare informs about loss of share certificate | <div>Ttk Healthcare has informed that it enclosed Certificate under Reg 39(3) of SEBI (LODR), 2015 - Loss of Share Certificate.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 03-Nov-2023 | Ttk Healthcare submits unaudited financial results | <div style="text-align: justify;">Ttk Healthcare has informed that it enclosed the Unaudited Financial Results along with the Limited Review Report from the Statutory Auditors of the Company, for the Second Quarter and Half-Year ended 30th September, 2023, duly reviewed by the Audit Committee at their meeting held yesterday on 2nd November, 2023 and approved by the Board of Directors of the Company at their Meeting held today.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;"><br></div> |
| 17-Aug-2023 | TTK Healthcare informs about details of loss of certificate | <div style="text-align: justify;">Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, TTK Healthcare has informed that Radhika Bahl jointly with Ajay Bahl who holds shares, has reported loss/ misplacement of Share Certificates. Radhika Bahl jointly with Ajay Bahl has already filed its Claim with the IEPF Authority, upon verification of the documents received from them, the Company shall file the E-verification Report accordingly.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 26-May-2023 | TTK Healthcare informs about secretarial compliance report | <p style="text-align: justify;">In accordance with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, TTK Healthcare has forwarded the Secretarial Compliance Report dated 12th May, 2023, for the financial year ended 31st March, 2023, issued by Balu Sridhar, Partner, A K Jain & Associates, Practising Company Secretaries, Chennai 600084.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p> |
